Back to search results

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-Small Cell Lung Cancer · NSCLC · Advanced Non-Small Cell Lung Cancer · Metastatic Non Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Virginia Commonwealth University, Richmond, Virginia, United States

    Contact: Study coordinator (Massey Lung Team) · masseylung@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Jonathan Berkman, MD)

  • VCU Health Tappahannock Hospital, Tappahannock, Virginia, United States

    Contact: Study coordinator (Massey CTO Lung Team) · masseylung@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Jonathan Berkman, MD)
Study leads

  • Jonathan Berkman, MD

    Principal Investigator

    Virginia Commonwealth University

View source on ClinicalTrials.gov(opens in a new tab)